Research Medical Center is a 590-bed hospital located in Kansas City, Missouri at 2316 East Meyer Boulevard. It is part of the HCA Midwest Division.

There are 590 beds in Research Medical Center.

During the past decade, Research Medical Center conducted 115 clinical trials. In the 10-year time frame, 115 clinical trials started and 159 clinical trials were completed, i.e. on average, 138.3% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 83 clinical trials were completed. i.e. 360.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Research Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 83 trials, followed by "SWOG Cancer Research Network" with 50 trials sponsored, "Alliance for Clinical Trials in Oncology" with 36 trials sponsored, "SCRI Development Innovations, LLC" with 17 trials sponsored and "Gynecologic Oncology Group" with 17 trials sponsored. Other sponsors include 103 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Research Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 131 trials as a collaborator, "NRG Oncology" with 19 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 8 trials as a collaborator and "Genentech, Inc." with 7 trials as a collaborator. Other collaborators include 148 different institutions and companies that were collaborators in the rest 95 trials.

According to Clinical.Site data, the most researched conditions in "Research Medical Center" are "Breast Cancer" (23 trials), "Colorectal Cancer" (13 trials), "Lung Cancer" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Leukemia" (8 trials). Many other conditions were trialed in "Research Medical Center" in a lesser frequency.

Most popular intervention types in "Research Medical Center" are "Drug" (225 trials), "Other" (142 trials), "Biological" (78 trials), "Procedure" (44 trials) and "Radiation" (29 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (74 trials), "Quality-of-Life Assessment" (42 trials), "Carboplatin" (21 trials), "Paclitaxel" (21 trials) and "Bevacizumab" (20 trials). Other intervention names were less common.

The vast majority of trials in "Research Medical Center" are 249 trials for "All" genders, 50 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Research Medical Center". 2 are not yet recruiting, 24 are recruiting, 109 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 142 completed trials in Research Medical Center, 1 suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Research Medical Center, 11 "Phase 1" clinical trials were conducted, 125 "Phase 2" clinical trials and 128 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 25 trials that are defined as “Not Applicable".